A new way to understand how cancer cells survive drugs

A new framework explains how some cancer cells stay alive during targeted therapy.

Researchers introduced a general phenomenological framework. This model helps understand how phenotypic plasticity creates drug persisters.

Drug persisters are cells that survive targeted therapy. They are often quiescent but sometimes return to cycling.

Phenotypic plasticity is a way that gives rise to drug persisters. Drug persisters can eventually lead to mutants with true resistance.

The framework uses observations of variations between and among single-cell clones. It also looks at how the drug itself might enhance survival strategies.

The approach predicts an optimum drug concentration exists. It also predicts an optimum drug holiday schedule to minimize the persistence-based threat.

Key facts

  • Drug persisters can survive targeted therapy and lead to true resistance.
  • The framework predicts an optimum drug concentration and an optimum drug holiday schedule.
  • Phenotypic plasticity can give rise to drug persisters.

All sections

Edition